Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab
Paolo Lopedote,1 Mazyar Shadman2,3 1Department of Medicine, St Elizabeth’s Medical Center, Boston, MA, USA; 2Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; 3Department of Medicine, University of Washington, Seattle, WA, USACorrespondence: Mazyar Shadman, Clinical Resear...
| Autores principales: | , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2023-03-01
|
| Colección: | Cancer Management and Research |
| Materias: | |
| Acceso en línea: | https://www.dovepress.com/targeted-treatment-of-relapsed-or-refractory-follicular-lymphoma-focus-peer-reviewed-fulltext-article-CMAR |